Skip to main content

Advertisement

SpringerLink
Log in

Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The endothelial cell-specific form of nitric oxide synthase (eNOS) may play an important role in tumor progression via angiogenesis or apoptosis. We studied eNOS −786T > C and 894G > T (Glu298Asp), two functionally significant SNPs, in relation to hazard of breast cancer recurrence or death in 873 women with incident, non-metastatic breast cancer, recruited from two teaching hospitals in Seoul, Korea, 1995–2002. Hazards were estimated by Cox proportional hazard models, in relation to genotype, adjusting for hormone receptor status, lymph node involvement, and tumor size. Women carriers of the eNOS −786C allele had significantly increased hazards of breast cancer recurrence or death, compared with women having the TT genotype (HR = 2.1, 95% CI = 1.03–4.33); risks increased up to 3-fold in ER positive cases (HR = 3.2, 95% CI = 0.95–10.50). The hazard was also increased in eNOS 894T carriers, however, it did not reach statistical significance (HR = 1.8, 95% CI = 0.85–3.93). The combined genotypes containing −786C or 894T was associated with a 2.5-fold risk, compared to the TT–GG genotypes, the most dominant genotype combination (95% CI = 1.29–4.68), with the greatest risks in ER positive cases (HR = 4.9, 95% CI = 1.31–18.36). These results indicate that the eNOS −786C polymorphism, and possibly the 894T polymorphism, are associated with breast cancer recurrence and death, particularly in women with ER positive tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mortensen K, Skouv J, Hougaard DM, Larsson LI (1999) Endogenous endothelial cell nitric-oxide synthase modulates apoptosis in cultured breast cancer cells and is transcriptionally regulated by p53. J Biol Chem 274:37679–37684

    Article  PubMed  CAS  Google Scholar 

  2. Hu DE, Dyke SO, Moore AM, Thomsen LL, Brindle KM (2004) Tumor cell-derived nitric oxide is involved in the immune-rejection of an immunogenic murine lymphoma. Cancer Res 64:152–161

    Article  PubMed  CAS  Google Scholar 

  3. Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG (2002) The role of nitric oxide in cancer. Cell Res 12:311–320

    Article  PubMed  Google Scholar 

  4. Martin JH, Begum S, Alalami O, Harrison A, Scott KW (2000) Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer. Tumour Biol 21:90–97

    Article  PubMed  CAS  Google Scholar 

  5. Mortensen K, Holck S, Christensen IJ, Skouv J, Hougaard DM, Blom J, Larsson LI (1999) Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patients. Clin Cancer Res 5:1093–1097

    PubMed  CAS  Google Scholar 

  6. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K (1999) T-786–>C mutation in the 5’-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864–2870

    PubMed  CAS  Google Scholar 

  7. McDonald DM, Alp NJ, Channon KM (2004) Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 14:831–839

    Article  PubMed  CAS  Google Scholar 

  8. Hefler LA, Ludwig E, Lampe D, Zeillinger R, Leodolter S, Gitsch G, Koelbl H, Tempfer CB (2002) Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol 86:134–137

    Article  PubMed  CAS  Google Scholar 

  9. Medeiros RM, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Ferreira P, Lopes C (2002) Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clin Cancer Res 8:3433–3437

    PubMed  CAS  Google Scholar 

  10. Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, Gitsch G, Leodolter S, Tempfer CB (2004) Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol Oncol 93:686–690

    Article  PubMed  CAS  Google Scholar 

  11. Ghilardi G, Biondi ML, Cecchini F, DeMonti M, Guagnellini E, Scorza R (2003) Vascular invasion in human breast cancer is correlated to T–>786C polymorphism of NOS3 gene. Nitric Oxide 9:118–122

    Article  PubMed  CAS  Google Scholar 

  12. Choi JY, Lee KM, Park SK, Noh DY, Ahn SH, Chung HW, Han W, Kim JS, Shin SG, Jang IJ, Yoo KY, Hirvonen A, Kang D (2005) Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer. Cancer Epidemiol Biomarkers Prev 14:1090–1095

    Article  PubMed  CAS  Google Scholar 

  13. Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY (2005) A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea. Clin Cancer Res 11:4775–4778

    Article  PubMed  CAS  Google Scholar 

  14. Wang J, Dudley D, Wang XL (2002) Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 22:e1–e4

    Article  PubMed  Google Scholar 

  15. Ahsan A, Norboo T, Baig MA, Qadar Pasha MA (2005) Simultaneous selection of the wild-type genotypes of the G894T and 4B/4A polymorphisms of NOS3 associate with high-altitude adaptation. Ann Hum Genet 69:260–267

    PubMed  CAS  Google Scholar 

  16. Jadeski LC, Chakraborty C, Lala PK (2003) Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase. Int J Cancer 106:496–504

    Article  PubMed  CAS  Google Scholar 

  17. Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, Welters I, Fricchione GL, Breton C, Lassalle P, Salzet M, Bilfinger TV (2000) Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 101:1594–1597

    PubMed  CAS  Google Scholar 

  18. Kakui K, Itoh H, Sagawa N, Yura S, Korita D, Takemura M, Miyamaoto Y, Saito Y, Nakao K, Fujii S (2004) Augmented endothelial nitric oxide synthase (eNOS) protein expression in human pregnant myometrium: possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER)alpha and ERbeta. Mol Hum Reprod 10:115–122

    Article  PubMed  CAS  Google Scholar 

  19. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J (1998) Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245:190–193

    Article  PubMed  CAS  Google Scholar 

  20. Amoli MM, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA (2003) Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. J Rheumatol 30:2019–2022

    PubMed  CAS  Google Scholar 

Download references

Acknowledgement

This study was supported by the Korean Health 21 R&D Project, Korean Ministry of Health & Welfare, R. O. K (Grant No. 03-PJ10-PG13-GD01-0002).

Author information

Authors and Affiliations

  1. Department of Epidemiology, Roswell Park Cancer Institute, Buffalo, NY, USA

    Ji-Yeob Choi

  2. Occupational and Environmental Epidemiology Branch, National Cancer Institute, Bethesda, MD, USA

    Kyoung-Mu Lee, Richard B Hayes & Daehee Kang

  3. Department of General Surgery, Seoul National University College of Medicine, Seoul, Korea

    Dong-Young Noh & Wonshik Han

  4. Department of General Surgery, Ulsan University College of Medicine, Seoul, Korea

    Sei-Hyun Ahn

  5. DNA Link Inc., Seoul, Korea

    Jong-Eun Lee

  6. Department of Pharmacology, Seoul National University College of Medicine, Seoul, Korea

    In-Jin Jang & Sang-Goo Shin

  7. Department of Preventive Medicine, Seoul National University College of Medicine, 28 Yongon-Dong Chongno-Gu, Seoul, 110-799, Korea

    Keun-Young Yoo & Daehee Kang

  8. Department of Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

    Daehee Kang

Authors
  1. Ji-Yeob Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kyoung-Mu Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dong-Young Noh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sei-Hyun Ahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jong-Eun Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wonshik Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. In-Jin Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sang-Goo Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Keun-Young Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Richard B Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Daehee Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daehee Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, JY., Lee, KM., Noh, DY. et al. Genetic Polymorphisms of eNOS, Hormone Receptor Status, and Survival of Breast Cancer. Breast Cancer Res Treat 100, 213–218 (2006). https://doi.org/10.1007/s10549-006-9245-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9245-5

Keywords

Search

Navigation